KR102237960B1 - 위암 진단용 microrna 바이오마커 - Google Patents

위암 진단용 microrna 바이오마커 Download PDF

Info

Publication number
KR102237960B1
KR102237960B1 KR1020177003456A KR20177003456A KR102237960B1 KR 102237960 B1 KR102237960 B1 KR 102237960B1 KR 1020177003456 A KR1020177003456 A KR 1020177003456A KR 20177003456 A KR20177003456 A KR 20177003456A KR 102237960 B1 KR102237960 B1 KR 102237960B1
Authority
KR
South Korea
Prior art keywords
mir
hsa
mirna
mirnas
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177003456A
Other languages
English (en)
Korean (ko)
Other versions
KR20170035932A (ko
Inventor
헹-폰 투
리한 저우
뤠이양 조우
카이 관 여
복 얀 소
펭 주
웨이 펭 용
Original Assignee
에이전시 포 사이언스, 테크놀로지 앤드 리서치
내셔널 유니버시티 오브 싱가포르
내셔널 유니버시티 호스피탈 (싱가포르) 피티이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이전시 포 사이언스, 테크놀로지 앤드 리서치, 내셔널 유니버시티 오브 싱가포르, 내셔널 유니버시티 호스피탈 (싱가포르) 피티이 리미티드 filed Critical 에이전시 포 사이언스, 테크놀로지 앤드 리서치
Priority to KR1020217009878A priority Critical patent/KR102604163B1/ko
Publication of KR20170035932A publication Critical patent/KR20170035932A/ko
Application granted granted Critical
Publication of KR102237960B1 publication Critical patent/KR102237960B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G01N33/57407—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
KR1020177003456A 2014-08-07 2015-08-11 위암 진단용 microrna 바이오마커 Active KR102237960B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217009878A KR102604163B1 (ko) 2014-08-07 2015-08-11 위암 진단용 microrna 바이오마커

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201404742W 2014-08-07
SG10201404742W 2014-08-07
PCT/SG2015/050256 WO2016022076A1 (en) 2014-08-07 2015-08-11 Microrna biomarker for the diagnosis of gastric cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217009878A Division KR102604163B1 (ko) 2014-08-07 2015-08-11 위암 진단용 microrna 바이오마커

Publications (2)

Publication Number Publication Date
KR20170035932A KR20170035932A (ko) 2017-03-31
KR102237960B1 true KR102237960B1 (ko) 2021-04-08

Family

ID=55264222

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020177003456A Active KR102237960B1 (ko) 2014-08-07 2015-08-11 위암 진단용 microrna 바이오마커
KR1020217009878A Active KR102604163B1 (ko) 2014-08-07 2015-08-11 위암 진단용 microrna 바이오마커

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020217009878A Active KR102604163B1 (ko) 2014-08-07 2015-08-11 위암 진단용 microrna 바이오마커

Country Status (7)

Country Link
US (1) US10767230B2 (enExample)
EP (3) EP3744859B1 (enExample)
JP (3) JP6702935B2 (enExample)
KR (2) KR102237960B1 (enExample)
CN (1) CN107109470B (enExample)
SG (2) SG10202011339RA (enExample)
WO (1) WO2016022076A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102237960B1 (ko) * 2014-08-07 2021-04-08 에이전시 포 사이언스, 테크놀로지 앤드 리서치 위암 진단용 microrna 바이오마커
EP3294910B1 (en) * 2015-05-08 2021-03-17 Agency For Science, Technology And Research Method for diagnosis and prognosis of chronic heart failure
CN106636334B (zh) * 2016-10-09 2020-07-03 山东大学 microRNA标志物组及其在制备检测胃癌淋巴结转移试剂盒中的应用
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
CN106755377B (zh) * 2016-12-12 2021-05-25 浙江省中医院 一种胃癌血清学检测鉴定试剂盒及方法
EP3601564A4 (en) * 2017-03-23 2021-03-31 Quadrant Biosciences Inc. PROCESS FOR DIAGNOSING OR MONITORING CONDITIONS CHARACTERIZED BY ABNORMAL TEMPORAL VARIATIONS, PROCESS FOR NORMALIZING EPIGENETIC DATA TO COMPENSATE FOR TEMPORAL VARIATIONS
CL2017002289A1 (es) 2017-09-08 2019-08-16 Univ Pontificia Catolica Chile Método no invasivo de diagnóstico temprano de cáncer gástrico, usando como biomarcador los niveles de metilación de la secuencia de adn del promotor del microrna -335-5p
CN107723366B (zh) * 2017-09-11 2019-10-01 朱伟 一种与贲门癌辅助诊断相关的血清miRNA标志物及其应用
CN107746880B (zh) * 2017-11-01 2018-12-14 健生生物技术有限公司 一种基于RT-qPCR法检测胃癌的试剂盒及其制备方法和应用
CN108611414A (zh) * 2018-04-26 2018-10-02 北京工业大学 新的靶向肿瘤微环境与肺癌干细胞相互作用的miRNA的检测及应用
CN108743617A (zh) * 2018-05-03 2018-11-06 武汉科技大学 miR-15a-5p在提高CAR-T细胞抗肿瘤能力中的应用
EP3812461A4 (en) * 2018-06-21 2022-03-23 Public University Corporation Nagoya City University STOMACH CANCER BIOMARKER AND ITS USE
KR102089559B1 (ko) * 2018-08-31 2020-03-16 차의과학대학교 산학협력단 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
EP3899052A4 (en) * 2018-12-19 2023-02-22 Agency For Science, Technology And Research PROCESS
WO2020132494A2 (en) * 2018-12-21 2020-06-25 Baylor Research Institute Methods for prognosing, diagnosing, and treating gastric cancer
CN110066870B (zh) * 2019-04-12 2021-12-14 江苏省人民医院（南京医科大学第一附属医院） hsa-miR-382-5p在制备诊断视网膜变性疾病的试剂盒中的应用
CN117683886A (zh) * 2019-04-30 2024-03-12 觅瑞实验室私人有限公司 一种检测胃癌的miRNA标志物组合及试剂盒
KR102288359B1 (ko) * 2019-12-06 2021-08-10 주식회사 레피겐엠디 면역력 감소에 의한 질병의 발병 위험 예측용 다중 유전자 마커 및 이를 이용한 질병의 발병 위험 예측 방법
CN111471764B (zh) * 2019-12-27 2023-09-15 陈锦飞 一种用于筛查或辅助诊断胃癌的生物标志物组合及其试剂盒和应用
JP7511823B2 (ja) * 2020-01-24 2024-07-08 株式会社The IT Lab ｍｉＲＮＡの発現レベルをがんの確定診断の前のスクリーニングの指標として用いるがんの診断を補助する方法
CN111471683B (zh) * 2020-04-15 2021-09-07 湖南省科域生物医药科技有限公司 miR-93-5p作为诊断和治疗胃癌标志物的应用
KR102489708B1 (ko) * 2020-09-14 2023-01-18 서울대학교산학협력단 GDF11 유전자의 발현을 조절하는 PCBP2와 microRNA를 함유하는 조성물
CN112226514B (zh) * 2020-11-23 2021-08-03 苏州京脉生物科技有限公司 用于早期胃癌检测的标志物组合、试剂盒及其应用
CN112941185B (zh) * 2021-03-26 2023-06-23 杭州医学院 miR-29a作为标志物在制备恶性间皮瘤检测试剂盒中的应用
CN113151477B (zh) * 2021-05-08 2022-04-15 武汉大学中南医院 用于检测肠癌的miRNA标记物及其应用
CN113186285B (zh) * 2021-05-10 2022-05-24 深圳市展行生物有限公司 一种辅助诊断胃癌的方法及其使用的miRNA组合
CN113913516B (zh) * 2021-05-26 2023-08-29 东莞市松山湖中心医院(东莞市石龙人民医院、东莞市第三人民医院、东莞市心血管病研究所) hsa_circ_0006470作为靶点在制备miR-27b-3p的调节剂的应用
JP7406059B1 (ja) 2022-10-20 2023-12-27 防衛装備庁長官 急性ストレス評価用データの生成方法
WO2024229279A2 (en) * 2023-05-02 2024-11-07 Dana-Farber Cancer Institute, Inc. Use of circulating microrna profiles for identification of brca1 or brca2 mutations
CN118547069B (zh) * 2024-05-14 2025-08-22 北京热景生物技术股份有限公司 一种基于细胞外囊泡miRNA的胃癌诊断标志物及其应用
CN119580829A (zh) * 2024-11-25 2025-03-07 苏州大学 一种早期胃癌检测的标志物识别方法及诊断模型构建方法
CN119351558A (zh) * 2024-12-10 2025-01-24 西藏自治区人民政府驻成都办事处医院 一种检测胃癌的标志物、检测试剂盒及药物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012010584A1 (en) 2010-07-20 2012-01-26 Febit Holding Gmbh Complex mirna sets as novel biomarkers for gastric cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2487261B1 (en) * 2006-01-05 2015-07-01 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
AU2013245505B2 (en) * 2006-01-05 2016-06-23 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
EP3064584A3 (en) 2008-02-28 2016-12-07 The Ohio State University Research Foundation Micro rna-based methods and compositions for the diagnosis, prognosis and treatmentof gastric cancer
US9765334B2 (en) 2008-06-01 2017-09-19 Rosetta Genomics, Ltd. Compositions and methods for prognosis of gastric cancer
CN101988059B (zh) 2009-07-30 2014-04-02 江苏命码生物科技有限公司 胃癌检测标记物及其检测试剂盒和生物芯片
US9939442B2 (en) 2011-09-08 2018-04-10 The Regents Of The University Of California Salivary biomarkers for gastric cancer detection
JP2013085542A (ja) 2011-10-21 2013-05-13 Sysmex Corp 胃癌の検出方法、胃癌の血液マーカーおよびその使用
GB201317887D0 (en) * 2013-10-09 2013-11-20 Reneuron Ltd Product
CN103773761B (zh) * 2014-01-14 2016-01-20 南京医科大学 检测胃癌的血清/血浆微小rna标志物及其应用
CN103937888B (zh) * 2014-04-14 2016-08-17 上海交通大学 鉴别胃癌的血浆microRNA标志物的筛选与应用
KR102237960B1 (ko) * 2014-08-07 2021-04-08 에이전시 포 사이언스, 테크놀로지 앤드 리서치 위암 진단용 microrna 바이오마커

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012010584A1 (en) 2010-07-20 2012-01-26 Febit Holding Gmbh Complex mirna sets as novel biomarkers for gastric cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Br J Cancer, 109(9): 2323-2330 (2013.10.08.)*

Also Published As

Publication number Publication date
KR20170035932A (ko) 2017-03-31
EP3744859A2 (en) 2020-12-02
JP2017525350A (ja) 2017-09-07
JP2020141684A (ja) 2020-09-10
SG11201700944RA (en) 2017-03-30
CN107109470B (zh) 2020-09-15
JP6702935B2 (ja) 2020-06-03
JP7635186B2 (ja) 2025-02-25
CN107109470A (zh) 2017-08-29
JP7614735B2 (ja) 2025-01-16
EP4137586A1 (en) 2023-02-22
KR20210057079A (ko) 2021-05-20
KR102604163B1 (ko) 2023-11-20
EP3744859A3 (en) 2021-03-17
EP3177739B1 (en) 2019-10-23
EP3177739A4 (en) 2018-05-02
US10767230B2 (en) 2020-09-08
EP3744859B1 (en) 2025-05-07
EP3177739A1 (en) 2017-06-14
SG10202011339RA (en) 2020-12-30
WO2016022076A1 (en) 2016-02-11
US20170233822A1 (en) 2017-08-17
JP2022188053A (ja) 2022-12-20

Similar Documents

Publication Publication Date Title
KR102237960B1 (ko) 위암 진단용 microrna 바이오마커
AU2017246318A1 (en) Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna
US20140100124A1 (en) Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
WO2013011378A1 (en) Diagnostic microrna profiling in cutaneous t-cell lymphoma (ctcl)
KR102096498B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로RNA-4732-5p 및 이의 용도
CN103384829A (zh) 预测大肠直肠癌复发的生物标记
US20220180973A1 (en) Early detection and prediction method of pan-cancer
WO2013160176A1 (en) Diagnostic mirna profiles in multiple sclerosis
US20180251836A1 (en) Novel mirna biomarkers and use thereof
EP3529376A1 (en) Biomarkers of oral, pharyngeal and laryngeal cancers
US20240254566A1 (en) Analysis method, kit, and detection device
CN113832079A (zh) 肠道微生物组合及其作为系统性红斑狼疮标志物的应用
KR102096499B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로rna-3960 및 이의 용도
CN113789289A (zh) 评估系统性红斑狼疮患病风险的肠道微生物组合及其检测试剂
WO2025105011A1 (en) Method for determining pancreatic cancer
KR20190113108A (ko) 대장암 진단 또는 재발 예측을 위한 마이크로rna-3656 및 이의 용도
KR20190113100A (ko) 대장암 진단 또는 재발 예측을 위한 마이크로RNA-320c 및 이의 용도
CN114540501A (zh) 用于诊断非小细胞肺癌的miRNA及其应用
CN113832080A (zh) 系统性红斑狼疮疾病标志性肠道微生物组合及其应用
CN105002177A (zh) 检测脂肪肉瘤的小rna指纹图谱及其应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000